{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T20:13:40Z","timestamp":1774296820788,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.vaccine.2013.02.025","type":"journal-article","created":{"date-parts":[[2013,2,26]],"date-time":"2013-02-26T08:01:19Z","timestamp":1361865679000},"page":"1905-1915","source":"Crossref","is-referenced-by-count":35,"title":["Heterologous priming\u2013boosting with DNA and vaccinia virus expressing kinetoplastid membrane protein-11 induces potent cellular immune response and confers protection against infection with antimony resistant and sensitive strains of Leishmania (Leishmania) donovani"],"prefix":"10.1016","volume":"31","author":[{"given":"Rajan","family":"Guha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shantanabha","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"June","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kshudiram","family":"Naskar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashok","family":"Mandala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shyam","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Claude","family":"Dujardin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syamal","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"January (1)","key":"10.1016\/j.vaccine.2013.02.025_bib0005","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"Croft","year":"2006","journal-title":"Clin Microbiol Rev"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2013.02.025_bib0010","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1093\/infdis\/jis424","article-title":"Genetic markers for SSG resistance in Leishmania donovani and SSG treatment failure in visceral leishmaniasis patients of the Indian subcontinent","volume":"206","author":"Vanaerschot","year":"2012","journal-title":"J Infect Dis"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2013.02.025_bib0015","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1473-3099(10)70011-6","article-title":"Combination therapy for visceral leishmaniasis","volume":"10","author":"van Griensven","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2013.02.025_bib0020","doi-asserted-by":"crossref","first-page":"e943","DOI":"10.1371\/journal.pntd.0000943","article-title":"Vaccines for the leishmaniases: proposals for a research agenda","volume":"5","author":"Costa","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2013.02.025_bib0025","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1146\/annurev.immunol.18.1.927","article-title":"DNA vaccines: immunology, application, and optimization","volume":"18","author":"Gurunathan","year":"2000","journal-title":"Annu Rev Immunol"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2013.02.025_bib0030","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1128\/IAI.69.8.4719-4725.2001","article-title":"Leishmania donovani p36 (LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis","volume":"69","author":"Melby","year":"2001","journal-title":"Infect Immun"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2013.02.025_bib0035","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1128\/IAI.73.2.812-819.2005","article-title":"Cross-protective efficacy of a prophylactic Leishmania donovani DNA vaccine against visceral and cutaneous murine leishmaniasis","volume":"73","author":"Aguilar-Be","year":"2005","journal-title":"Infect Immun"},{"issue":"January (5)","key":"10.1016\/j.vaccine.2013.02.025_bib0040","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.vaccine.2007.11.044","article-title":"Immunization with the cysteine proteinase Ldccys1 gene from Leishmania (Leishmania) chagasi and the recombinant Ldccys1 protein elicits protective immune responses in a murine model of visceral leishmaniasis","volume":"26","author":"Ferreira","year":"2008","journal-title":"Vaccine"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2013.02.025_bib0045","doi-asserted-by":"crossref","first-page":"7064","DOI":"10.4049\/jimmunol.165.12.7064","article-title":"Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis","volume":"165","author":"Stager","year":"2000","journal-title":"J Immunol"},{"issue":"December (20)","key":"10.1016\/j.vaccine.2013.02.025_bib0050","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/S0264-410X(98)00075-9","article-title":"Vaccination with recombinant Parasite Surface Antigen 2 from Leishmania major induces a Th1 type of immune response but does not protect against infection","volume":"16","author":"Sjolander","year":"1998","journal-title":"Vaccine"},{"issue":"May (20)","key":"10.1016\/j.vaccine.2013.02.025_bib0055","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.vaccine.2008.03.003","article-title":"Immunization strategies against visceral leishmaniosis with the nucleosomal histones of Leishmania infantum encoded in DNA vaccine or pulsed in dendritic cells","volume":"26","author":"Carrion","year":"2008","journal-title":"Vaccine"},{"issue":"February (7)","key":"10.1016\/j.vaccine.2013.02.025_bib0060","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.vaccine.2009.11.075","article-title":"Cellular and humoral responses induced by Leishmania histone H2B and its divergent and conserved parts in cutaneous and visceral leishmaniasis patients, respectively","volume":"28","author":"Meddeb-Garnaoui","year":"2010","journal-title":"Vaccine"},{"issue":"June (11)","key":"10.1016\/j.vaccine.2013.02.025_bib0065","doi-asserted-by":"crossref","first-page":"7160","DOI":"10.4049\/jimmunol.174.11.7160","volume":"174","author":"Basu","year":"2005","journal-title":"J Immunol"},{"issue":"February (9)","key":"10.1016\/j.vaccine.2013.02.025_bib0070","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.vaccine.2008.12.053","article-title":"KMP-11 DNA immunization significantly protects against L. donovani infection but requires exogenous IL-12 as an adjuvant for comparable protection against L. major","volume":"27","author":"Bhaumik","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.02.025_bib0075","first-page":"2115","article-title":"Towards development of novel immunization strategies against leishmaniasis using PLGA nanoparticles loaded with kinetoplastid membrane protein-11","volume":"7","author":"Santos","year":"2012","journal-title":"Int J Nanomed"},{"issue":"March (5)","key":"10.1016\/j.vaccine.2013.02.025_bib0080","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/infdis\/jir842","article-title":"Therapeutic vaccination with recombinant adenovirus reduces splenic parasite burden in experimental visceral leishmaniasis","volume":"205","author":"Maroof","year":"2012","journal-title":"J Infect Dis"},{"issue":"May (9)","key":"10.1016\/j.vaccine.2013.02.025_bib0085","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1086\/513439","article-title":"HLA class I-restricted T cell epitopes of the kinetoplastid membrane protein-11 presented by Leishmania donovani-infected human macrophages","volume":"195","author":"Basu","year":"2007","journal-title":"J Infect Dis"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2013.02.025_bib0090","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1128\/IAI.01490-06","article-title":"Heterologous priming\u2013boosting with DNA and modified vaccinia virus Ankara expressing tryparedoxin peroxidase promotes long-term memory against Leishmania major in susceptible BALB\/c Mice","volume":"75","author":"Stober","year":"2007","journal-title":"Infect Immun"},{"issue":"September (19)","key":"10.1016\/j.vaccine.2013.02.025_bib0095","doi-asserted-by":"crossref","first-page":"10817","DOI":"10.1073\/pnas.181123498","article-title":"Induction of CD4(+) T cell-dependent CD8(+) type 1 responses in humans by a malaria DNA vaccine","volume":"98","author":"Wang","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2013.02.025_bib0100","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.1128\/IAI.73.8.5286-5289.2005","article-title":"Heterologous prime-boost vaccination with the LACK antigen protects against murine visceral leishmaniasis","volume":"73","author":"Dondji","year":"2005","journal-title":"Infect Immun"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2013.02.025_bib0105","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0167-5699(00)01612-1","article-title":"The prime-boost strategy: exciting prospects for improved vaccination","volume":"21","author":"Ramshaw","year":"2000","journal-title":"Immunol Today"},{"key":"10.1016\/j.vaccine.2013.02.025_bib0110","first-page":"171","article-title":"Prime-boost strategies in DNA vaccines","volume":"127","author":"Dale","year":"2006","journal-title":"Methods Mol Med"},{"issue":"March (1\u20133)","key":"10.1016\/j.vaccine.2013.02.025_bib0115","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0165-2478(98)00164-3","article-title":"Pre-clinical development of a multi-CTL epitope-based DNA prime MVA boost vaccine for AIDS","volume":"66","author":"Hanke","year":"1999","journal-title":"Immunol Lett"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2013.02.025_bib0120","doi-asserted-by":"crossref","first-page":"10180","DOI":"10.1128\/JVI.72.12.10180-10188.1998","article-title":"Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus","volume":"72","author":"Kent","year":"1998","journal-title":"J Virol"},{"issue":"January (7\u20138)","key":"10.1016\/j.vaccine.2013.02.025_bib0125","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0264-410X(01)00427-3","article-title":"A heterologous prime-boost regime using DNA and recombinant vaccinia virus expressing the Leishmania infantum P36\/LACK antigen protects BALB\/c mice from cutaneous leishmaniasis","volume":"20","author":"Gonzalo","year":"2002","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2013.02.025_bib0130","doi-asserted-by":"crossref","first-page":"e7880","DOI":"10.1371\/journal.pone.0007880","article-title":"Immunogenicity and efficacy of single antigen Gp63, polytope and polytopeHSP70 DNA vaccines against visceral Leishmaniasis in experimental mouse model","volume":"4","author":"Sachdeva","year":"2009","journal-title":"PLoS ONE"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2013.02.025_bib0135","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1128\/MCB.5.12.3403","article-title":"Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques","volume":"5","author":"Chakrabarti","year":"1985","journal-title":"Mol Cell Biol"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2013.02.025_bib0140","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.4049\/jimmunol.175.4.2517","article-title":"IL-10 from regulatory T cells determines vaccine efficacy in murine Leishmania major infection","volume":"175","author":"Stober","year":"2005","journal-title":"J Immunol"},{"issue":"November (13\u201314)","key":"10.1016\/j.vaccine.2013.02.025_bib0145","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.ijpara.2011.07.013","article-title":"Characterisation of antimony-resistant Leishmania donovani isolates: biochemical and biophysical studies and interaction with host cells","volume":"41","author":"Mukhopadhyay","year":"2011","journal-title":"Int J Parasitol"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2013.02.025_bib0150","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat Med"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2013.02.025_bib0155","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1084\/jem.20070590","article-title":"A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism","volume":"204","author":"Coombes","year":"2007","journal-title":"J Exp Med"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2013.02.025_bib0160","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.4049\/jimmunol.143.12.4244","article-title":"Experimental visceral leishmaniasis: role of endogenous IFN-gamma in host defense and tissue granulomatous response","volume":"143","author":"Squires","year":"1989","journal-title":"J Immunol"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2013.02.025_bib0165","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.1128\/IAI.68.11.6289-6293.2000","article-title":"Visceral leishmaniasis in mice devoid of tumor necrosis factor and response to treatment","volume":"68","author":"Murray","year":"2000","journal-title":"Infect Immun"},{"issue":"November (2)","key":"10.1016\/j.vaccine.2013.02.025_bib0170","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1128\/IAI.42.2.702-707.1983","article-title":"Cell-mediated immune response in Indian kala-azar and post-kala-azar dermal leishmaniasis","volume":"42","author":"Haldar","year":"1983","journal-title":"Infect Immun"},{"issue":"June (8)","key":"10.1016\/j.vaccine.2013.02.025_bib0175","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0264-410X(96)00271-X","article-title":"Enhancement of immunodeficiency virus-specific immune responses in DNA-immunized rhesus macaques","volume":"15","author":"Fuller","year":"1997","journal-title":"Vaccine"},{"issue":"October (5388)","key":"10.1016\/j.vaccine.2013.02.025_bib0180","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.282.5388.476","article-title":"Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine","volume":"282","author":"Wang","year":"1998","journal-title":"Science"},{"issue":"August","key":"10.1016\/j.vaccine.2013.02.025_bib0185","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1600-065X.1999.tb01326.x","article-title":"Induction of CD8+ T cells using heterologous prime-boost immunisation strategies","volume":"170","author":"Schneider","year":"1999","journal-title":"Immunol Rev"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2013.02.025_bib0190","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nri2274","article-title":"T-cell quality in memory and protection: implications for vaccine design","volume":"8","author":"Seder","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2013.02.025_bib0195","doi-asserted-by":"crossref","first-page":"e1000484","DOI":"10.1371\/journal.ppat.1000484","article-title":"Vector transmission of leishmania abrogates vaccine-induced protective immunity","volume":"5","author":"Peters","year":"2009","journal-title":"PLoS Pathog"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2013.02.025_bib0200","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1128\/IAI.71.1.401-410.2003","article-title":"Intradermal infection model for pathogenesis and vaccine studies of murine visceral leishmaniasis","volume":"71","author":"Ahmed","year":"2003","journal-title":"Infect Immun"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2013.02.025_bib0205","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.4049\/jimmunol.175.5.3214","article-title":"Leishmania donovani affects antigen presentation of macrophage by disrupting lipid rafts","volume":"175","author":"Chakraborty","year":"2005","journal-title":"J Immunol"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2013.02.025_bib0210","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1002\/eji.200737504","article-title":"Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations","volume":"37","author":"Beveridge","year":"2007","journal-title":"Eur J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2013.02.025_bib0215","doi-asserted-by":"crossref","first-page":"e38859","DOI":"10.1371\/journal.pone.0038859","article-title":"High quality long-term CD4+ and CD8+ effector memory populations stimulated by DNA-LACK\/MVA-LACK regimen in Leishmania major BALB\/c model of infection","volume":"7","author":"Sanchez-Sampedro","year":"2012","journal-title":"PLoS ONE"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2013.02.025_bib0220","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1046\/j.1365-2567.2003.01589.x","article-title":"A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis","volume":"108","author":"Skinner","year":"2003","journal-title":"Immunology"},{"issue":"June\u2013August (3\u20134)","key":"10.1016\/j.vaccine.2013.02.025_bib0225","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1359-6101(03)00022-4","article-title":"Biological functions of tumor necrosis factor cytokines and their receptors","volume":"14","author":"Pfeffer","year":"2003","journal-title":"Cytokine Growth Factor Rev"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2013.02.025_bib0230","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.4049\/jimmunol.145.12.4306","article-title":"Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide","volume":"145","author":"Liew","year":"1990","journal-title":"J Immunol"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2013.02.025_bib0235","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/eji.1830200528","article-title":"Tumor necrosis factor-alpha in combination with interferon-gamma, but not with interleukin 4 activates murine macrophages for elimination of Leishmania major amastigotes","volume":"20","author":"Bogdan","year":"1990","journal-title":"Eur J Immunol"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2013.02.025_bib0240","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2249.2011.04536.x","article-title":"Multifunctional CD4(+) T cells in patients with American cutaneous leishmaniasis","volume":"167","author":"Macedo","year":"2012","journal-title":"Clin Exp Immunol"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2013.02.025_bib0245","doi-asserted-by":"crossref","first-page":"e1000431","DOI":"10.1371\/journal.ppat.1000431","article-title":"B7-H1 blockade increases survival of dysfunctional CD8(+) T cells and confers protection against Leishmania donovani infections","volume":"5","author":"Joshi","year":"2009","journal-title":"PLoS Pathog"},{"issue":"July\u2013August (4)","key":"10.1016\/j.vaccine.2013.02.025_bib0250","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0035-9203(03)90071-X","article-title":"Skewing of cytokine profiles towards T helper cell type 2 response in visceral leishmaniasis patients unresponsive to sodium antimony gluconate","volume":"97","author":"Thakur","year":"2003","journal-title":"Trans R Soc Trop Med Hyg"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13001886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13001886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T13:38:13Z","timestamp":1715002693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13001886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":50,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0264410X13001886"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.02.025","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}